Tatsusnori Shimoi

25PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyCross-sectional analysisMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 26, 2026
Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy.

|Jun 22, 2026
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

|May 13, 2026
Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

|Mar 11, 2026
Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study.

Kazuki Yokoyama, Kazunori Honda, Kazuko Matsumoto

|Feb 26, 2026
Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection.

Taro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi

|Jan 16, 2026
Cancer genome profiling in sarcomas: current status and future perspectives in Japan.

Tatsusnori Shimoi, Shosuke Kita, Kan Yonemori

Pageof 5

Frequent Collaborators

6 joint publications

Emi Noguchi

6 joint publications

Kan Yonemori

5 joint publications

Kazuki Sudo

4 joint publications

Hitomi Sumiyoshi-Okuma